Biolinq’s Post

The medical device and medtech industry is undergoing significant changes, which is evident in the rising value of the global medical devices market from approximately $542.2 billion in 2024 to $886 billion by 2032. Read more to learn about the top 10 trends for the medical device and medtech industry in 2024: https://buff.ly/4cduhEE #MedicalDevice #MedTech #AI #MachineLearning #WearableDevice #WearableTechnology #WearableDevices #HealthWearables #RemotePatientMonitoring

The European Medtech Industry: A Beacon of Innovation The European #Medtech industry, valued at an estimated €192bn in 2022, is revolutionising patient care through groundbreaking medical devices and cutting-edge digital health wearables. Recent reports highlight a surge in AI-based patent applications within Medtech, underscoring the industry's unwavering commitment to pioneering advancements. https://lnkd.in/eHqUe9pt Secerna LLP is a trusted partner for innovators navigating the intellectual property landscapes of Medtech. With expertise that transforms regulatory frameworks into enablers of innovation, Secerna is committed to ensuring that Medtech continues to lead the dynamic stage of medical technology. #Medtech #Innovation #Patenting #EuropeanMedtech #IndustryLeadership #AI #Patent #IntellectualProperty

#Pharma artificial intelligence serves as a game-changer in patient journey mapping by its ability to process and analyze vast amounts of data at unprecedented speed and scale. #AI algorithms can seamlessly integrate data from diverse sources, including electronic health records, claims data, wearable devices, social media, and more, providing a comprehensive and cohesive view of the patient’s journey. For instance, AI-driven platforms can handle data from multiple #healthcare providers, creating a unified patient profile that enhances the accuracy of analysis and decision-making. These capabilities enable #pharmaceutical companies to gain insights that might have been otherwise unattainable with traditional methods. https://lnkd.in/eT4TwDjV

MedTech Syndicates has unveiled to me the vast expanse of innovations within the medical technology arena. From cutting-edge wearables that monitor our health in real-time to Class III implantable medical devices that promise groundbreaking healthcare solutions – the possibilities seem limitless. 🧫 Each innovation carries the promise of a healthier tomorrow and a world where healthcare is more accessible and effective. For all the MedTech enthusiasts out there, I challenge you: If you could champion one new to market technological breakthrough in the MedTech world, what would it be? 🤖 #MedTechSyndicates #SeedFundingJourney #MedTech #SeedFunding

Worthen Industries is making a significant impact in the medical industry with our cutting-edge pressure-sensitive adhesives. As highlighted in the recent article "Pressure-sensitive medical adhesives: In search of the holy grail" by Med-Tech Innovation these adhesives play a crucial role in the development of medical devices that cater to the diverse needs of healthcare professionals and patients. At Worthen, we understand that these materials are foundational building blocks for essential medical devices like wound care dressings and wearables, requiring exceptional performance capabilities. Providing reliable and innovative solutions, we are proud to support the advancement of healthcare. Curious to learn more about our Medical capabilities? Click here: https://lnkd.in/gsk-9pv6. To dive into the full article, check it out here: https://lnkd.in/g9wZzWTp #WorthenIndustries #MedicalIndustry #PressureSensitiveAdhesives #healthcareinnovation

🔬🩺 Exciting Developments in Health Tech! 🌟 Abbott and Dexcom are revolutionizing glucose monitoring with new sensors designed for people without diabetes. Abbott introduced 'Lingo,' a wearable that tracks glucose spikes and lows, designed for optimal well-being. Priced at £150/month, users receive two sensors and an app that focuses on monitoring glucose spikes throughout the day. This innovation could contribute significantly to Abbott's goal of achieving $10 billion in Libre business sales by 2028. Dexcom, on the other hand, is targeting Type 2 diabetes patients who don't take insulin with a new CGM based on its G7 device. This development reflects the shift toward broader metabolic health monitoring. Both companies are expanding their reach beyond diabetes, offering innovative solutions for a healthier future. 🌐📈 Stay updated on cutting-edge medical technologies! Subscribe to MedVerse for more breakthroughs in healthcare. 🔗💡 #HealthTech #MedicalInnovation #GlucoseMonitoring #Abbott #Dexcom #MedVerse For more exciting updates in the world of medical technology, visit our website: www.cae-consultants.com. 🌐🔬

#Pharma artificial intelligence serves as a game-changer in patient journey mapping by its ability to process and analyze vast amounts of data at unprecedented speed and scale. #AI algorithms can seamlessly integrate data from diverse sources, including electronic health records, claims data, wearable devices, social media, and more, providing a comprehensive and cohesive view of the patient’s journey. For instance, AI-driven platforms can handle data from multiple #healthcare providers, creating a unified patient profile that enhances the accuracy of analysis and decision-making. These capabilities enable #pharmaceutical companies to gain insights that might have been otherwise unattainable with traditional methods. https://lnkd.in/ev6zjY-m

In 2023, the U.S. healthcare expenditure will approach $6.0 trillion. Key medical trends include advanced wearable devices, AI-driven drug discovery, evolving nanomedicine, and expanded telemedicine, addressing healthcare accessibility and innovation. Learn more here: https://bit.ly/3sLoEvb #MedTecht #Technology #Advances #Healthcare

I have a question for the LinkedIn brains trust, relating to #Software as a #Medical device. I am attending the #QUT Bridgetech Program this year (Medtech commercialisation and research pathways). During this weeks meeting discussions turned to the regulatory landscape associated with #SaMD and medical grade wearables. Scenario: "Many medical grade wearable devices that are collecting data offer the option to transfer this data to EMR,s or data aggregation software via an open API. In the above scenario and after integration, there are now three (if the API is registered as SaMD) separately listed medical systems working together to deliver a solution". Question: How should this combined solution be recognised by our regulatory bodies? What are the potential legal and regulatory ramifications for the three independent companies should there be a failure in 1, 2 or all 3 of the integrated systems.? As an adjunct , I did ask an AI tool the above question and it provided some interesting, if not jurisdictional answers. The main one being that the 3 systems should be registered as a combined system under a new listing. I wont comment other than saying, I cant see this happening. 🤐 Cant wait to hear your thoughts. #medtech #QUT #Bridgetech #regulation

Tech Revolutionizing #DrugDevelopment In recent years, technology has revolutionized drug development processes in #lifesciences. From #cloudcomputing to #AI and APIs, innovative digital tools ensure compliance and speed up progress. Digitalization not only optimizes clinical trials but also addresses patient recruitment and retention issues. It's breaking barriers, reaching untapped patient populations, and enhancing the overall patient experience. In the COVID era, electronic outcome assessment (eCOA) tools have gained ground, reducing costs and improving compliance. Participants now use their devices, seamlessly woven into their routines, streamlining data collection. As this trend continues, expect a wave of specialized apps and wearable devices. The future of drug development is undoubtedly digital Clinixir is a leading contract research organization in #Thailand, providing full-service clinical research solutions for medical innovations. For more information contact Clinixir at enquiries@clinixir.com or https://lnkd.in/gBEu96q2. To learn more about Clinixir’s services, please visit www.clinixir.com